Home >> Cardiovascular Devices >> Advertising & Marketing >> Food & Beverage >>

United States Cardiovascular Devices Market Outlook to 2016

Published: May-2010 | Format: PDF | GlobalData | Number of pages: 345 | Code: MRS - 844

GlobalDatas new report, US Cardiovascular Devices Market Outlook to 2016 provides key market data on the US cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

Market size and company share data for seven cardiovascular devices market categories Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices.
Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
2009 company shares and distribution shares data for each of the seven market categories.
Global corporate-level profiles of key companies operating within the US cardiovascular devices market.
Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical Inc., Cordis Corporation., Abbott Laboratories, Terumo Corporation and C.R. Bard, Inc.

Reasons to buy

Develop business strategies by identifying the key market categories and segments poised for strong growth.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the US cardiovascular devices competitive landscape.
Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.


Table Of Contents

1 Table of Contents
1 Table of Contents
1.1 List of Tables 
1.2 List of Figures 

2 Introduction
2.1 What Is This Report About? 

3 Cardiovascular Devices In United States
3.1 Cardiovascular Devices, Market Segmentation 
3.2 Cardiovascular Devices, United States, Overall Revenue ($m), 2002-2016 
3.3 Cardiovascular Devices Market, United States, Revenue Mix ($m), 2009 
3.4 Cardiovascular Devices Market, United States, Category Contribution (%), 2009 
3.5 Cardiovascular Devices, United States, Category Volume (Units), 2002-2016 
3.6 Cardiovascular Devices, United States, Company Share (2008-2009) 

4 Cardiac Rhythm Management In United States
4.1 Cardiac Rhythm Management, Market Segmentation 
4.2 Cardiac Rhythm Management Market, United States, Revenue Mix ($m), 2009 
4.3 Cardiac Rhythm Management Market, United States, Category Contribution (%), 2009 
4.4 Cardiac Rhythm Management Overall Revenue (2002-2016) 
4.4.1 Cardiac Resynchronisation Therapy Revenue (2002-2016) 
4.4.2 Implantable Cardioverter Defibrillator Revenue (2002-2016) 
4.4.3 Pacemaker Revenue (2002-2016) 
4.4.4 External Defibrillator Revenue (2002-2016) 
4.5 Cardiac Rhythm Management Overall Volume (2002-2016) 
4.5.1 Cardiac Resynchronisation Therapy Volume (2002-2016) 
4.5.2 Implantable Cardioverter Defibrillator Volume (2002-2016) 
4.5.3 Pacemaker Volume (2002-2016) 
4.5.4 External Defibrillator Volume (2002-2016) 
4.6 Cardiac Rhythm Management Average Price (2002-2016) 
4.7 Cardiac Rhythm Management Distribution Share (2008-2009) 
4.1 Cardiac Rhythm Management, United States, Company Share (2008-2009) 

5 Cardiovascular Monitoring and Diagnostic Devices In United States
5.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 
5.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue Mix ($m), 2009 
5.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Category Contribution (%), 2009 
5.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2002-2016) 
5.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2002-2016) 
5.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2002-2016) 
5.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2008-2009) 
5.8 Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share (2008-2009) 

6 Cardiovascular Prosthetic Devices In United States
6.1 Cardiovascular Prosthetic Devices, Market Segmentation 
6.2 Cardiovascular Prosthetic Devices Market, United States, Revenue Mix ($m), 2009 
6.3 Cardiovascular Prosthetic Devices Market, United States, Category Contribution (%), 2009 
6.4 Cardiovascular Prosthetic Devices Overall Revenue (2002-2016) 
6.4.1 Cardiac Assist Devices Revenue (2002-2016) 
6.4.2 Prosthetic Heart Valve Revenue (2002-2016) 
6.5 Cardiovascular Prosthetic Devices Overall Volume (2002-2016) 
6.5.1 Cardiac Assist Devices Volume (2002-2016) 
6.5.2 Prosthetic Heart Valve Volume (2002-2016) 
6.6 Cardiovascular Prosthetic Devices Average Price (2002-2016) 
6.7 Cardiovascular Prosthetic Devices Distribution Share (2008-2009) 
6.8 Cardiovascular Prosthetic Devices, United States, Company Share (2008-2009) 

7 Cardiovascular Surgery In United States
7.1 Cardiovascular Surgery, Market Segmentation 
7.2 Cardiovascular Surgery Market, United States, Revenue Mix ($m), 2009 
7.3 Cardiovascular Surgery Market, United States, Category Contribution (%), 2009 
7.4 Cardiovascular Surgery Overall Revenue (2002-2016) 
7.4.1 Perfusion Disposables Revenue (2002-2016) 
7.5 Cardiovascular Surgery Overall Volume (2002-2016) 
7.5.1 Perfusion Disposables Volume (2002-2016) 
7.6 Cardiovascular Surgery Average Price (2002-2016) 
7.7 Cardiovascular Surgery Distribution Share (2008-2009) 
7.8 Cardiovascular Surgery, United States, Company Share (2008-2009) 

8 Electrophysiology In United States
8.1 Electrophysiology, Market Segmentation 
8.2 Electrophysiology Market, United States, Revenue Mix ($m), 2009 
8.3 Electrophysiology Market, United States, Category Contribution (%), 2009 
8.4 Electrophysiology Overall Revenue (2002-2016) 
8.5 Electrophysiology Overall Volume (2002-2016) 
8.6 Electrophysiology Average Price (2002-2016) 
8.7 Electrophysiology Distribution Share (2008-2009) 
8.8 Electrophysiology, United States, Company Share (2008-2009) 

9 Interventional Cardiology In United States
9.1 Interventional Cardiology, Market Segmentation 
9.2 Interventional Cardiology Market, United States, Revenue Mix ($m), 2009 
9.3 Interventional Cardiology Market, United States, Category Contribution (%), 2009 
9.4 Interventional Cardiology Overall Revenue (2002-2016) 
9.4.1 Cardiac Catheter Revenue (2002-2016) 
9.4.2 Coronary Stent Revenue (2002-2016) 
9.4.3 PTCA Balloon Revenue (2002-2016) 
9.5 Interventional Cardiology Overall Volume (2002-2016) 
9.5.1 Cardiac Catheter Volume (2002-2016) 
9.5.2 Coronary Stent Volume (2002-2016) 
9.5.3 PTCA Balloon Volume (2002-2016) 
9.6 Interventional Cardiology Average Price (2002-2016) 
9.7 Interventional Cardiology Distribution Share (2008-2009) 
9.8 Interventional Cardiology, United States, Company Share (2008-2009) 

10 Peripheral Vascular Devices In United States
10.1 Peripheral Vascular Devices, Market Segmentation 
10.2 Peripheral Vascular Devices Market, United States, Revenue Mix ($m), 2009 
10.3 Peripheral Vascular Devices Market, United States, Category Contribution (%), 2009 
10.4 Peripheral Vascular Devices Overall Revenue (2002-2016) 
10.5 Peripheral Vascular Devices Overall Volume (2002-2016) 
10.6 Peripheral Vascular Devices Average Price (2002-2016) 
10.7 Peripheral Vascular Devices Distribution Share (2008-2009) 
10.8 Peripheral Vascular Devices, United States, Company Share (2008-2009) 

11 Overview of Key Companies in United States Cardiovascular Devices Market
11.1 Medtronic, Inc. 
11.1.1 Company Overview 
11.1.2 Share in the United States Cardiovascular Devices Market 
11.2 Boston Scientific Corporation 
11.2.1 Company Overview 
11.2.2 Share in the United States Cardiovascular Devices Market 
11.3 St. Jude Medical, Inc. 
11.3.1 Company Overview 
11.3.2 Share in the United States Cardiovascular Devices Market 
11.4 Cordis Corporation 
11.4.1 Company Overview 
11.4.2 Share in the United States Cardiovascular Devices Market 
11.5 Abbott Laboratories 
11.5.1 Company Overview 
11.5.2 Share in the United States Cardiovascular Devices Market 
11.6 C. R. Bard, Inc. 
11.6.1 Company Overview 
11.7 AtriCure, Inc. 
11.7.1 Company Overview 
11.8 Biosense Webster, Inc. 
11.8.1 Company Overview 
11.9 Smiths Medical 
11.9.1 Company Overview 
11.10 CryoLife, Inc. 
11.10.1 Company Overview 
11.11 LeMaitre Vascular, Inc. 
11.11.1 Company Overview 
11.12 CONMED Corporation 
11.12.1 Company Overview 
11.13 Thoratec Corporation 
11.13.1 Company Overview 
11.14 GE Healthcare 
11.14.1 Company Overview 
11.15 Philips Healthcare 
11.15.1 Company Overview 
11.16 Edwards Lifesciences Corporation 
11.16.1 Company Overview 
11.17 Terumo Corporation 
11.17.1 Company Overview 
11.18 Welch Allyn Inc. 
11.18.1 Company Overview 
11.19 Nihon Kohden Corporation 
11.19.1 Company Overview 
11.20 Fukuda Denshi Co., Ltd. 
11.20.1 Company Overview 
11.21 OSI Systems, Inc. 
11.21.1 Company Overview 
11.22 BIOTRONIK SE & Co. KG 
11.22.1 Company Overview 
11.23 Schiller AG 
11.23.1 Company Overview 
11.24 ABIOMED, Inc. 
11.24.1 Company Overview 
11.25 Cardiac Science Corporation 
11.25.1 Company Overview 
11.26 MAQUET GmbH & Co. KG 
11.26.1 Company Overview 
11.27 Atritech, Inc. 
11.27.1 Company Overview 
11.28 Mortara Instrument, Inc. 
11.28.1 Company Overview 
11.29 ev3 Inc. 
11.29.1 Company Overview 
11.30 Sorin Group USA, Inc. 
11.30.1 Company Overview 
11.31 Kensey Nash Corporation 
11.31.1 Company Overview 
11.32 The Spectranetics Corporation 
11.32.1 Company Overview 
11.33 AngioDynamics, Inc. 
11.33.1 Company Overview 
11.34 ATS Medical, Inc. 
11.34.1 Company Overview 
11.35 Angeion Corporation 
11.35.1 Company Overview 
11.36 Atrion Corporation 
11.36.1 Company Overview 
11.37 Biotel Incorporated 
11.37.1 Company Overview 
11.38 Cardima, Inc. 
11.38.1 Company Overview 
11.39 CompuMed, Inc. 
11.39.1 Company Overview 
11.40 Cardium Therapeutics, Inc. 
11.40.1 Company Overview 
11.41 MicroMed Cardiovascular, Inc. 
11.41.1 Company Overview 
11.42 Utah Medical Products, Inc. 
11.42.1 Company Overview 
11.43 VNUS Medical Technologies, Inc. 
11.43.1 Company Overview 
11.44 Biosite Incorporated 
11.44.1 Company Overview 
11.45 CarboMedics Inc. 
11.45.1 Company Overview 
11.46 ZOLL Medical Corporation 
11.46.1 Company Overview 
11.47 Avalon Laboratories, Inc. 
11.47.1 Company Overview 
11.48 IncisionTech 
11.48.1 Company Overview 
11.49 Braemar, Inc. 
11.49.1 Company Overview 
11.50 Scion Cardio-Vascular, Inc. 
11.50.1 Company Overview 
11.51 Vasomedical, Inc. 
11.51.1 Company Overview 
11.52 Inovise Medical, Inc. 
11.52.1 Company Overview 
11.53 Atrium Medical Corporation 
11.53.1 Company Overview 
11.54 Cambridge Heart, Inc. 
11.54.1 Company Overview 
11.55 Merit Medical Systems, Inc. 
11.55.1 Company Overview 
11.56 AGA Medical Holdings, Inc. 
11.56.1 Company Overview 
11.57 Belmont Instrument Corporation 
11.57.1 Company Overview 
11.58 CardiacAssist, Inc. 
11.58.1 Company Overview 
11.59 Cardiac Dimensions, Inc. 
11.59.1 Company Overview 
11.60 World Heart Corporation 
11.60.1 Company Overview 
11.61 LifeWatch Corp. 
11.61.1 Company Overview 
11.62 Medispec LTD 
11.62.1 Company Overview 
11.63 MICOR, INC. 
11.63.1 Company Overview 
11.64 ACIST Medical Systems, Inc. 
11.64.1 Company Overview 
11.65 MRI Medical 
11.65.1 Company Overview 
11.66 Medicomp, Inc. 
11.66.1 Company Overview 
11.67 Braemar Distribution 
11.67.1 Company Overview 
11.68 Allvivo Vascular, Inc. 
11.68.1 Company Overview 
11.69 CIVCO Medical Solutions 
11.69.1 Company Overview 
11.70 AngioScore, Inc. 
11.70.1 Company Overview 
11.71 Cardiovascular Systems, Inc. 
11.71.1 Company Overview 
11.72 Viacor, Inc. 
11.72.1 Company Overview 
11.73 Fehling Surgical Instruments, Inc. 
11.73.1 Company Overview 
11.74 eCardio Diagnostics LLC 
11.74.1 Company Overview 
11.75 Endovalve, Inc. 
11.75.1 Company Overview 
11.76 Theregen, Inc. 
11.76.1 Company Overview 
11.77 FlowCardia, Inc. 
11.77.1 Company Overview 
11.78 Genesis Medical Interventional, Inc. 
11.78.1 Company Overview 
11.79 XTENT, Inc. 
11.79.1 Company Overview 
11.80 Cardiva Medical, Inc. 
11.80.1 Company Overview 
11.81 Shelhigh, Inc. 
11.81.1 Company Overview 
11.82 Surge Medical Solutions, LLC 
11.82.1 Company Overview 
11.83 Heart Tronics, Inc. 
11.83.1 Company Overview 
11.84 Greatbatch, Inc. 
11.84.1 Company Overview 
11.85 Medtronic CoreValve, LLC 
11.85.1 Company Overview 
11.86 Mitralign, Inc. 
11.86.1 Company Overview 
11.87 BioCardia, Inc. 
11.87.1 Company Overview 
11.88 Mercator MedSystems, Inc. 
11.88.1 Company Overview 
11.89 Vascular Technology, Inc. 
11.89.1 Company Overview 
11.90 Bolton Medical, Inc. 
11.90.1 Company Overview 
11.91 SynCardia Systems, Inc. 
11.91.1 Company Overview 
11.92 Cardiac Output Technologies, Inc. 
11.92.1 Company Overview 
11.93 Hancock Jaffe Laboratories, Inc. 
11.93.1 Company Overview 
11.94 Applied Medical Resources Corporation 
11.94.1 Company Overview 
11.95 Interventional Imaging, Inc. 
11.95.1 Company Overview 
11.96 HeartSine Technologies, Inc. 
11.96.1 Company Overview 
11.97 Coherex Medical, Inc. 
11.97.1 Company Overview 
11.98 Remon Medical Technologies, Inc. 
11.98.1 Company Overview 
11.99 EVAHEART MEDICAL USA, INC. 
11.99.1 Company Overview 
11.100 Integrated Medical Devices, Inc. 
11.100.1 Company Overview 
11.101 Lake Region Manufacturing, Inc. 
11.101.1 Company Overview 

12 Cardiovascular Devices Market Pipeline Products

13 Financial Deals Landscape
13.1 Merger 
13.1.1 Avinger Merges With Sawtooth Labs 
13.2 Acquisition 
13.2.1 Gambro Acquires CHF Solutions 
13.2.2 Abbott Laboratories Acquires Evalve 
13.2.3 Banner Boswell Medical Acquires Sun City Cardiac Center From MedCath 
13.2.4 SANUWAVE Completes Reverse Acquisition With Rub Music Enterprises 
13.2.5 Bederra To Acquire Basic Solutions 
13.2.6 St. Jude Medical Acquires Stake In Micell Technologies 
13.2.7 SonoSite Completes Acquisition Of CardioDynamics International 
13.2.8 Vanderbilt Medical Center Acquires The Cardiac Center 
13.2.9 Philips Healthcare Completes Acquisition Of INNERCOOL therapies From Cardium Therapeutics 
13.2.10 CardioNet Terminates Acquisition Of Biotel 

14 Recent Developments
14.1 Strategy And Business Planning 
14.1.1 Apr 30, 2010: Medical City Hospital Partners With Dallas Fire-Rescue 
14.1.2 Apr 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support 
14.1.3 Mar 19, 2010: Terumo Cardiovascular Systems Unveils New Manufacturing Plant At Ann Arbor 
14.1.4 Feb 24, 2010: Zynex Announces Development Of Two New Business Units 
14.1.5 Feb 17, 2010: Greatbatch Medical Opens New Orthopaedic Design Center In Warsaw, Indiana 
14.1.6 Feb 15, 2010: Sensible Medical Innovations Opens Columbus Office 
14.1.7 Feb 11, 2010: St. Jude Medical Expands In Austin, Texas 
14.1.8 Jan 13, 2010: IDev Technologies Unveils New Manufacturing Plant In Texas 
14.2 Research And Development 
14.2.1 May 15, 2010: New Medtronic Data Shows Health Care Utilisation Differs By Implantable Defibrillator Therapy Type 
14.2.2 May 13, 2010: St. Jude Medical Presents FREEDOM Clinical Trial At Heart Rhythm 2010 
14.2.3 May 13, 2010: New Data Demonstrate Safety, Efficacy Of Stereotaxis For Patients With AFIB, VT And Congenital Defects 
14.2.4 May 13, 2010: Medtronic Releases Virtual ICD Study Results At Heart Rhythm 2010 
14.2.5 May 13, 2010: Medtronic Releases New Evidence On Shock Reduction Device Programming Strategies At Heart Rhythm 2010 
14.2.6 Apr 08, 2010: Biosense Webster Obtains Ethics Committee Approval For Clarity Study 
14.2.7 Feb 26, 2010: Researchers Believe Stents Safe, Effective In Narrow Neck Arteries 
14.2.8 Jan 25, 2010: MAQUET Cardiovascular Presents Long-Term Follow-Up Data Of SMART Study 
14.2.9 Dec 01, 2009: nContact Initiates Clinical Trials For The Treatment Of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 
14.2.10 Sep 24, 2009: Results From Abbott's PROSPECT Study Provide New Insight Into Role Of Vulnerable Plaque In Coronary Artery Disease 
14.3 Legal and Regulatory 
14.3.1 May 04, 2010: DOJ Demands Documents On ICDs: St. Jude Medical 
14.3.2 Apr 27, 2010: Boston Scientific Expresses Willingness To Discuss Modification Of Guidant Plea Agreement 
14.3.3 Apr 13, 2010: Boston Scientific Files Appeal In Stent Patent Dispute Against Cordis 
14.3.4 Apr 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific 
14.3.5 Apr 05, 2010: Guidant Pleads Guilty For Not Reporting Defibrillator Safety Problems To FDA 
14.3.6 Apr 01, 2010: Medtronic To Appeal Jury Verdict In US Patent Case Involving CoreValve Transcatheter Aortic Valve System 
14.3.7 Mar 30, 2010: DOJ, SEC Seeks Information On Boston Scientific Defibrillator Recall 
14.3.8 Mar 29, 2010: AGA Medical Settles Patent Dispute With Medtronic 
14.3.9 Mar 25, 2010: Greatbatch Introducer Patent Infringement Verdict Vacated 
14.3.10 Mar 24, 2010: CoreValve Wins Another Round In Patent War With Edwards Lifesciences 
14.3.11 Mar 18, 2010: Coughlin Stoia Files Class Action Suit Against St. Jude Medical 
14.3.12 Mar 12, 2010: Sorin Announces Tentative Settlement Of Investigation By Department Of Justice 
14.3.13 Mar 10, 2010: Medtronic: US Attorneys In Massachusetts Seeks Information On Clinic Relationship 
14.3.14 Mar 05, 2010: Boston Scientific Files Cross-Appeal In Stent Patent Disputes Against Johnson & Johnson 
14.3.15 Feb 25, 2010: Guidant Charged With Federal Crimes Related To June 2005 Defibrillator Recalls 
14.3.16 Feb 24, 2010: Whistleblower Lawsuit Alleges Medtronic Over Marketing Of Biliary Stents 
14.3.17 Feb 02, 2010: AtriCure Announces Definitive Settlement With The Department Of Justice 
14.3.18 Feb 01, 2010: Cordis Settles Coronary Stent Patent Disputes With Boston Scientific 
14.3.19 Jan 20, 2010: Boston Scientific Says Court Rules Johnson & Johnson Patents Invalid 
14.3.20 Jan 19, 2010: Edwards Lifesciences' Transcatheter Valve Patent Found Valid In German Court 
14.3.21 Jan 13, 2010: Endologix Says USPTO Granted Its Requests For Reexamination Of Two Patents Asserted By Cook 
14.3.22 Jan 11, 2010: Holzer Holzer & Fistel Is Investigating Potential Violations Of Federal Securities Laws By St. Jude Medical 
14.4 Government and Public Interest 
14.4.1 May 13, 2010: Cardiac Procedure Significantly Reduces Risk Of Alzheimer's Disease And Stroke: Intermountain Medical Center 
14.4.2 May 12, 2010: New Melody Transcatheter Pulmonary Valve Helps Congenital Heart Defect Patients Avoid Multiple Surgeries: U-M C.S. Mott Children’s Hospital 
14.4.3 May 11, 2010: FDA Warns St. Jude Medical Over Epicor Surgical Ablation Devices To Treat A-Fib 
14.4.4 May 06, 2010: SCAI Announces Formation Of Accreditation For Cardiovascular Excellence 
14.4.5 Apr 29, 2010: UC Davis Research Team Documents Benefits Of Endovascular Stent Repair For Traumatic Aortic Injury 
14.4.6 Apr 26, 2010: HeartWare Initiates Repairs And Partial Recall Of Controllers 
14.4.7 Apr 21, 2010: ISHLT Announces New Guidelines For Heart Transplant Recipients 
14.4.8 Apr 21, 2010: Coronary CTA Cost-Effective, Non-Invasive Alternative To Invasive Cardiac Catheterization To Assess CAD: Thomas Jefferson University 
14.4.9 Apr 20, 2010: FDA To Address Challenges Of Using Complex Medical Devices In Home 
14.4.10 Apr 20, 2010: Minneapolis Heart Institute Cardiologists Urge Federal Judge To Reject Guidant's Plea Agreement 
14.4.11 Apr 16, 2010: Hospira Receives FDA Warning Letter For Two North Carolina Facilities 
14.4.12 Apr 15, 2010: Boston Scientific To Resume Distribution Of Cognis CRT-Ds, Teligen ICDs In US 
14.4.13 Apr 13, 2010: FDA Plans Public Workshop On Computer Methods For Cardiovascular Devices 
14.4.14 Apr 13, 2010: FDA Soon Will Decide On Boston Scientific's Defibrillator Issue 
14.4.15 Apr 12, 2010: Valve-In-Valve Implants Via Catheter Effective In High-Risk Patients 
14.4.16 Apr 12, 2010: Risk Of Complications, Death In Aged May Increase After Implantation Of Cardiac Devices 
14.4.17 Apr 06, 2010: Edwards Lifesciences Comments On FDA Warning Letter 
14.4.18 Mar 25, 2010: New Tissue-Hugging Implant Maps Heart Electrical Activity In Unprecedented Detail 
14.4.19 Mar 23, 2010: Cardiologist Uses Device Like A Dental Drill To Reopen Arteries 
14.4.20 Mar 19, 2010: SAMMPRIS Study Aims To Identify Best Suitable Treatment For Stroke 
14.4.21 Mar 17, 2010: More Research Needed To Determine Best Treatment Of Multi-Vessel Coronary Artery Disease During Primary PCI For ST-Segment Elevation Myocardial Infarction 
14.4.22 Mar 17, 2010: Study Finds New Measurement Tool Better At Determining Cardiac Risk 
14.4.23 Mar 15, 2010: GE Healthcare Launches Clinical Visualization Tools At 2010 SIR 
14.4.24 Mar 15, 2010: Device Advances Interventional Radiology Treatment To Clear Blocked Carotid Arteries, Prevent Stroke 
14.4.25 Mar 10, 2010: Study Finds Need Of New Methods To Access Cardiac Catheterization Candidates 
14.4.26 Mar 09, 2010: New Method To Grow Arteries Could Lead To Biological Bypass For Heart Disease 
14.4.27 Mar 08, 2010: ECG Screening Of Hyperactive Children Borderline Cost-Effective 
14.4.28 Mar 02, 2010: Test Of Implantable Cardioverter Defibrillator Linked To Cognitive Problems 
14.4.29 Feb 26, 2010: NIH Clinical Trial Comparing Two Stroke Prevention Procedures Shows Surgery And Stenting Equally Safe And Effective 
14.4.30 Feb 17, 2010: National Imaging Associates Seeks To Optimize Outcomes With CardiacConnections Program 
14.4.31 Feb 16, 2010: New Study Finds Implanted Monitor Accurately Detects Heart Rhythm Disturbances 
14.4.32 Feb 09, 2010: Lack Of Foreign MDRs Results In Warning To ELA Medical 
14.4.33 Feb 04, 2010: NHLBI Funds Preclinical Tests On Devices For Infants And Children With Congenital Heart Defects 
14.4.34 Feb 02, 2010: FDA Plans Workshop On Pediatric Neurological And Neurocognitive Assessments For Cardiovascular Devices 
14.4.35 Jan 28, 2010: AHRQ And American College Of Cardiology Collaborate On Study Of Implantable Cardioverter Defibrillators 
14.4.36 Jan 13, 2010: Institute For Pediatric Innovation (IPI) And Its Pediatric Hospital Consortium Begin Engineering Development Of Two Innovative Devices Tailored For Infants 
14.4.37 Jan 07, 2010: UIC Cardiologists Repair The Heart Through The Wrist 
14.5 Product News 
14.5.1 May 12, 2010: St. Jude Medical To Showcase Arrhythmia Management Solutions At Heart Rhythm 2010 
14.5.2 May 10, 2010: AtriCure Receives FDA Conditional Approval For DEEP AF Feasibility Trial 
14.5.3 May 04, 2010: Edward Hospital Selects CardiacAssist’s TandemHeart System 
14.5.4 May 04, 2010: Stereotaxis Announces Updates From Multi-Center Clinical Study Of Niobe Magnetic Navigation System 
14.5.5 Apr 30, 2010: LightLab To Exhibit Products At SCAI Meeting 
14.5.6 Apr 26, 2010: St. Francis Hospital Selects CardiacAssist's TandemHeart 
14.5.7 Apr 23, 2010: Baptist Hospital East Selects CardiacAssist's TandemHeart 
14.5.8 Apr 21, 2010: Vascular Insights Unveils Clinical Trial Results Of ClariVein Catheter 
14.5.9 Apr 20, 2010: J&J Announces Rejection Of Application For Sedasys System By FDA And Provides Updates Of Pipeline Products 
14.5.10 Apr 15, 2010: Cardica Announces Publication Of Article On Advantages Of C-Port xA Distal and Flex-A Anastomosis Systems 
14.5.11 Apr 15, 2010: Cardica Announces Publication Of Safety And Efficacy Study Results Of C-Port xA Distal And Flex-A Anastomosis Systems In CABG Procedures 
14.5.12 Apr 15, 2010: Pathway Medical Technologies To Complete Phase IV For Jetstream G2 System In Second Half Of 2010 
14.5.13 Apr 14, 2010: OrbusNeich Medical Gains US Patent Entiled Stent With Helical Elements, Amends Lawsuit Against Boston Scientific 
14.5.14 Apr 13, 2010: Cook Medical Announces Global Adoption Of Zenith TX2 TAA Endovascular Graft With Pro-Form 
14.5.15 Apr 07, 2010: CardiacAssist Announces Completion Of 2000 Cases Using TandemHeart 
14.5.16 Mar 30, 2010: Risk Of Heart Disease Reduces With Chocolate Intake 
14.5.17 Mar 29, 2010: VNUS Medical Technologies To Complete TRIPLE Clinical Trial For ClosureRFS Stylet In First Half Of 2011 
14.5.18 Mar 24, 2010: TYRX Announces First Patient Enrollment In CITADEL Clinical Trial For AIGISRx 
14.5.19 Mar 19, 2010: MADIT-CRT Trial Leads To Recommendation For FDA Approval Of CRT-D 
14.5.20 Mar 15, 2010: Philips To Showcase Technology Advancements At ACC 2010 
14.5.21 Mar 12, 2010: St. Jude Medical To Showcase Robust Portfolio Of Products For Cardiac Care At ACC 2010 
14.5.22 Mar 12, 2010: Teleflex Updates On Voluntary Recall Of Arrow Select IV Tubing Sets, Accessories, And Certain Embolectomy Catheters 
14.5.23 Mar 08, 2010: CardiacAssist To Showcase TandemHeart System At American College Of Cardiology Annual Meeting 
14.5.24 Feb 23, 2010: TMP Initiates Worldwide Recall Of Transseptal Sheath Introducer Kits 
14.5.25 Feb 12, 2010: BIOTRONIK Enrolls Fist Patient In EchoCRT Study For Lumax 540 HF-T CRT-D 
14.5.26 Feb 10, 2010: Pitt County Memorial Hospital Installs CardiacAssist's TandemHeart System 
14.5.27 Feb 04, 2010: Cardiac Network Signs MOU With Pacific Innovations To Develop Cardiac Monitoring System 
14.5.28 Feb 04, 2010: SAMU Brasilia Selects ZOLL's AutoPulse Non-Invasive Cardiac Support Pump To Install In Ambulances 
14.5.29 Feb 03, 2010: Penrose-St. Francis Health Systems Selects CardiacAssist's TandemHeart 
14.5.30 Feb 02, 2010: Spectranetics Announces The Publication Of LExICon Study Results In Journal Of American College Of Cardiology 
14.5.31 Jan 27, 2010: Abiomed Signs Partnership Agreement With Opsens To Utilize Sensor Technology For Impella 
14.5.32 Jan 25, 2010: Abiomed Announces Webcast Of Impella 2.5 Procedure Featuring New Product Enhancements At Mount Sinai Medical Center 
14.5.33 Jan 19, 2010: Cook Showcases Latest Advancements For Treating Vascular Disease At ISET 2010 
14.5.34 Jan 19, 2010: CardiacAssist To Exhibit And Host TandemHeart Symposium At Society Of Thoracic Surgeons (STS) Annual Meeting 
14.5.35 Jan 14, 2010: St. Jude Medical To Display Its Products At Boston Atrial Fibrillation Symposium 2010 
14.5.36 Jan 14, 2010: Hansen Medical To Display Its New Sensei X Robotic Catheter System And New Catheters At Boston Atrial Fibrillation Symposium 
14.5.37 Jan 14, 2010: TYRX Announces First Patient Enrollment In CENTURION Study For AIGISRx ICD 
14.5.38 Jan 14, 2010: VF Medical To Distribute PD2i Analyzer From Vicor Technologies 
14.5.39 Jan 04, 2010: Boston Scientific Enrolls First Patient In Post-Approval Study For TAXUS Liberte Stent 

15 Appendix
15.1 Definitions of Markets Covered in the Report 
15.1.1 Cardiovascular Devices 
15.2 Research Methodology 
15.3 Secondary Research 
15.4 Primary Research 
15.5 Models 
15.6 Forecasts 
15.7 Expert Panels 
15.8 GlobalData Consulting 
15.9 Currency Conversion 
15.10 Contact Us 
15.11 Disclaimer 



List of Tables

Table 1: Cardiovascular Devices, United States, Overall Revenue ($m), 2002-2016 28
Table 2: Cardiovascular Devices Market, United States, Category Contribution (%), 2009 30
Table 3: Cardiovascular Devices Market, United States, Cross-Category Analysis,2002-2016 31
Table 4: Cardiovascular Devices, United States, Overall Revenue ($m), Historic, 2002-2009 33
Table 5: Cardiovascular Devices, United States, Overall Revenue ($m), Forecast, 2009-2016 35
Table 6: Cardiovascular Devices, United States, Category Volume (Units), 2002-2016 36
Table 7: Cardiovascular Devices, United States, Category Volume (Units), Historic, 2002-2009 38
Table 8: Cardiovascular Devices, United States, Category Volume (Units), Forecast, 2009-2016 40
Table 9: Cardiovascular Devices, United States, Company Share by Revenue ($m), 2008-2009 41
Table 10: Cardiac Rhythm Management Market, United States, Category Contribution (%), 2009 44
Table 11: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Historic, 2002-2009 46
Table 12: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Forecast, 2009-2016 47
Table 13: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 48
Table 14: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 49
Table 15: Implantable Cardioverter Defibrillator, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 50
Table 16: Implantable Cardioverter Defibrillator, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 51
Table 17: Pacemaker, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 52
Table 18: Pacemaker, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 53
Table 19: External Defibrillator, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 54
Table 20: External Defibrillator, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 55
Table 21: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Historic, 2002-2009 56
Table 22: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Forecast, 2009-2016 57
Table 23: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 58
Table 24: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 59
Table 25: Implantable Cardioverter Defibrillator, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 60
Table 26: Implantable Cardioverter Defibrillator, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 61
Table 27: Pacemaker, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 62
Table 28: Pacemaker, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 63
Table 29: External Defibrillator, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 64
Table 30: External Defibrillator, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 65
Table 31: Cardiac Rhythm Management, United States, Average Price ($), Historic, 2002-2009 66
Table 32: Cardiac Rhythm Management, United States, Average Price ($), Forecast, 2009-2016 67
Table 33: Cardiac Rhythm Management, United States, Distribution Share by Revenue ($m), 2008-2009 68
Table 34: Cardiac Rhythm Management, United States, Company Share by Revenue ($m), 2008-2009 70
Table 35: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Category Contribution (%), 2009 73
Table 36: Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($m) by Segment, Historic, 2002-2009 75
Table 37: Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($m) by Segment, Forecast, 2009-2016 76
Table 38: Cardiovascular Monitoring and Diagnostic Devices, United States, Volume (Units) by Segment, Historic, 2002-2009 77
Table 39: Cardiovascular Monitoring and Diagnostic Devices, United States, Volume (Units) by Segment, Forecast, 2009-2016 78
Table 40: Cardiovascular Monitoring and Diagnostic Devices, United States, Average Price ($), Historic, 2002-2009 79
Table 41: Cardiovascular Monitoring and Diagnostic Devices, United States, Average Price ($), Forecast, 2009-2016 79
Table 42: Cardiovascular Monitoring and Diagnostic Devices, United States, Distribution Share by Revenue ($m), 2008-2009 80
Table 43: Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share by Revenue ($m), 2008-2009 82
Table 44: Cardiovascular Prosthetic Devices Market, United States, Category Contribution (%), 2009 85
Table 45: Cardiovascular Prosthetic Devices, United States, Revenue ($m) by Segment, Historic, 2002-2009 86
Table 46: Cardiovascular Prosthetic Devices, United States, Revenue ($m) by Segment, Forecast, 2009-2016 87
Table 47: Cardiac Assist Devices, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 88
Table 48: Cardiac Assist Devices, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 89
Table 49: Prosthetic Heart Valve, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 90
Table 50: Prosthetic Heart Valve, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 91
Table 51: Cardiovascular Prosthetic Devices, United States, Volume (Units) by Segment, Historic, 2002-2009 92
Table 52: Cardiovascular Prosthetic Devices, United States, Volume (Units) by Segment, Forecast, 2009-2016 93
Table 53: Cardiac Assist Devices, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 94
Table 54: Cardiac Assist Devices, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 95
Table 55: Prosthetic Heart Valve, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 96
Table 56: Prosthetic Heart Valve, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 97
Table 57: Cardiovascular Prosthetic Devices, United States, Average Price ($), Historic, 2002-2009 98
Table 58: Cardiovascular Prosthetic Devices, United States, Average Price ($), Forecast, 2009-2016 99
Table 59: Cardiovascular Prosthetic Devices, United States, Distribution Share by Revenue ($m), 2008-2009 100
Table 60: Cardiovascular Prosthetic Devices, United States, Company Share by Revenue ($m), 2008-2009 102
Table 61: Cardiovascular Surgery Market, United States, Category Contribution (%), 2009 105
Table 62: Cardiovascular Surgery, United States, Revenue ($m) by Segment, Historic, 2002-2009 106
Table 63: Cardiovascular Surgery, United States, Revenue ($m) by Segment, Forecast, 2009-2016 107
Table 64: Perfusion Disposables, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 108
Table 65: Perfusion Disposables, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 109
Table 66: Cardiovascular Surgery, United States, Volume (Units) by Segment, Historic, 2002-2009 110
Table 67: Cardiovascular Surgery, United States, Volume (Units) by Segment, Forecast, 2009-2016 111
Table 68: Perfusion Disposables, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 112
Table 69: Perfusion Disposables, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 113
Table 70: Cardiovascular Surgery, United States, Average Price ($), Historic, 2002-2009 114
Table 71: Cardiovascular Surgery, United States, Average Price ($), Forecast, 2009-2016 114
Table 72: Cardiovascular Surgery, United States, Distribution Share by Revenue ($m), 2008-2009 115
Table 73: Cardiovascular Surgery, United States, Company Share by Revenue ($m), 2008-2009 117
Table 74: Electrophysiology Market, United States, Category Contribution (%), 2009 120
Table 75: Electrophysiology, United States, Revenue ($m) by Segment, Historic, 2002-2009 121
Table 76: Electrophysiology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 122
Table 77: Electrophysiology, United States, Volume (Units) by Segment, Historic, 2002-2009 123
Table 78: Electrophysiology, United States, Volume (Units) by Segment, Forecast, 2009-2016 124
Table 79: Electrophysiology, United States, Average Price ($), Historic, 2002-2009 125
Table 80: Electrophysiology, United States, Average Price ($), Forecast, 2009-2016 125
Table 81: Electrophysiology, United States, Distribution Share by Revenue ($m), 2008-2009 126
Table 82: Electrophysiology, United States, Company Share by Revenue ($m), 2008-2009 128
Table 83: Interventional Cardiology Market, United States, Category Contribution (%), 2009 131
Table 84: Interventional Cardiology, United States, Revenue ($m) by Segment, Historic, 2002-2009 133
Table 85: Interventional Cardiology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 135
Table 86: Cardiac Catheter, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 136
Table 87: Cardiac Catheter, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 137
Table 88: Coronary Stent, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 138
Table 89: Coronary Stent, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 139
Table 90: PTCA Balloon, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 140
Table 91: PTCA Balloon, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 141
Table 92: Interventional Cardiology, United States, Volume (Units) by Segment, Historic, 2002-2009 142
Table 93: Interventional Cardiology, United States, Volume (Units) by Segment, Forecast, 2009-2016 143
Table 94: Cardiac Catheter, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 144
Table 95: Cardiac Catheter, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 145
Table 96: Coronary Stent, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 146
Table 97: Coronary Stent, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 147
Table 98: PTCA Balloon, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 148
Table 99: PTCA Balloon, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 149
Table 100: Interventional Cardiology, United States, Average Price ($), Historic, 2002-2009 150
Table 101: Interventional Cardiology, United States, Average Price ($), Forecast, 2009-2016 151
Table 102: Interventional Cardiology, United States, Distribution Share by Revenue ($m), 2008-2009 152
Table 103: Interventional Cardiology, United States, Company Share by Revenue ($m), 2008-2009 154
Table 104: Peripheral Vascular Devices Market, United States, Category Contribution (%), 2009 157
Table 105: Peripheral Vascular Devices, United States, Revenue ($m) by Segment, Historic, 2002-2009 159
Table 106: Peripheral Vascular Devices, United States, Revenue ($m) by Segment, Forecast, 2009-2016 161
Table 107: Peripheral Vascular Devices, United States, Volume (Units) by Segment, Historic, 2002-2009 163
Table 108: Peripheral Vascular Devices, United States, Volume (Units) by Segment, Forecast, 2009-2016 165
Table 109: Peripheral Vascular Devices, United States, Average Price ($), Historic, 2002-2009 166
Table 110: Peripheral Vascular Devices, United States, Average Price ($), Forecast, 2009-2016 167
Table 111: Peripheral Vascular Devices, United States, Distribution Share by Revenue ($m), 2008-2009 168
Table 112: Peripheral Vascular Devices, United States, Company Share by Revenue ($m), 2008-2009 170
Table 113: Cardiovascular Devices Market Pipeline Products 209
Table 114: Avinger Merges With Sawtooth Labs 236
Table 115: Gambro Acquires CHF Solutions 237
Table 116: Abbott Laboratories Acquires Evalve 238
Table 117: Banner Boswell Medical Acquires Sun City Cardiac Center From MedCath 240
Table 118: SANUWAVE Completes Reverse Acquisition With Rub Music Enterprises 241
Table 119: Bederra To Acquire Basic Solutions 242
Table 120: St. Jude Medical Acquires Stake In Micell Technologies 243
Table 121: SonoSite Completes Acquisition Of CardioDynamics International 244
Table 122: Vanderbilt Medical Center Acquires The Cardiac Center 246
Table 123: Philips Healthcare Completes Acquisition Of INNERCOOL therapies From Cardium Therapeutics 247
Table 124: CardioNet Terminates Acquisition Of Biotel 249
Table 125: USD to Local Currency, United States, Average Actual Rate 2002-2009 345

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing